MESOBLASTIC NEPHROMA

This adverse event was reported 8 times

These drugs are most commonly taken by patients reporting MESOBLASTIC NEPHROMA:

# Drug Count
0 TRAMETINIB 2
1 ACETAMINOPHEN 1
2 ACETAMINOPHEN 500MG 1
3 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
4 CEFTAZIDIME 1
5 CRIZOTINIB 1
6 ETANERCEPT 1
7 GLYCEROL PHENYLBUTYRATE 1
8 LANSOPRAZOLE 1
9 LAROTRECTINIB 1
See all common drugs associated with MESOBLASTIC NEPHROMA

MESOBLASTIC NEPHROMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LAROTRECTINIB 1 0.0011
1 GLYCEROL PHENYLBUTYRATE 1 0.0007
2 CEFTAZIDIME 1 0.0001
3 TRAMETINIB 2 0.0001
4 CRIZOTINIB 1 0.0001
5 SENNOSIDES 8.6 MG TABLETS 1 0.0000
6 SENNA LEAF 1 0.0000
7 SENNOSIDES 1 0.0000
8 METHADONE 1 0.0000
9 ONDANSETRON HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with MESOBLASTIC NEPHROMA

MESOBLASTIC NEPHROMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
1 Kinase Inhibitor [EPC] 2 0.0000
2 Proton Pump Inhibitor [EPC] 1 0.0000
3 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with MESOBLASTIC NEPHROMA